Today, Maxiom Labs, Inc. (MAXIOM) officially launched its revolutionary AI platform designed to optimize health, fitness, and performance-for committed athletes and everyday achievers alike. After months of development, billions of data sets, and reinforcement learning built exclusively on the most-cited, peer-reviewed science-and shaped by feedback from thousands of users-MAXIOM secured investment from Switzerland-based genetics firm DNAthlete, closed an oversubscribed $2M seed round led by Conscious Ventures, and opened its $6M Series A. The company is now entering clinical trials to demonstrate that MAXIOM can match-and ultimately outperform-human experts. Its mission: to inspire and empower the full potential of one billion people.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527890937/en/
Founded by experts in AI, human performance, sports science, and precision medicine, MAXIOM combines deep technical rigor with decades of real-world coaching and clinical experience.
“Inside each of us is the blueprint for the best of us-but we’re drowning in noise and bad advice,” said Eric Harr, MAXIOM Co-Founder and CEO. “This is a decades-old, multi-trillion-dollar problem. We built MAXIOM to deliver truth, precision, and simplicity-to unlock human potential at scale.”
